您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[港股财报]:科笛-B2024年中期报告 - 发现报告

科笛-B2024年中期报告

2024-09-26港股财报坚***
AI智能总结
查看更多
科笛-B2024年中期报告

2024 2 4 6 7 17 34 35 36 38 39 (FCG, HKFCG) 97927 183401 13662805 2920 (FCG, HKFCG) 科笛集團 1617 Harneys Fiduciary (Cayman) Limited4th Floor, Harbour Place103 South Church StreetP.O. Box 10240Grand Cayman KY1-1002Cayman Islands 56 43620 1-102 3485 Harneys Fiduciary (Cayman) Limited4th Floor, Harbour Place103 South Church StreetP.O. Box 10240Grand Cayman KY1-1002Cayman Islands 02487 www.cutiatx.com 202363034.3178.3%202463095.62023123148%5202463053%2024630161.0 618GMVCUP-MNDEBailleul®16®2024121CUP-MNDEBailleul®®2024OTC®70%2024 CU-40102CU-40102NDACU-40102NDA2024120244NDA CU-102014%CU-10201NDACU-10201CU-1020120238CDENDA20239 科笛集團 CU-30101CU-30101CU-3010120247CU-20401CU-20401IICU-20401II20246CU-10101CU-10101CU-10101IND20245CDE20244 2019 CATAME® CU-40102 CU-40102NDAII5α- CU-40102CU-40102NDA2024120244NDA CU-102014% CU-10201NDACU-10201CU-1020120238CDENDA20239 CU-10101 CU-10101CU-10101 CU-10101IND20243CDE20245CDE CU-30101 CU-30101CU-30101CU-3010120241III20247 CU-20401 CU-20401CU-20401CU-20401CU-20401CU-20401IICU-20401II202462025II2028 科笛集團 618GMVCUP-MNDEBailleul®16®2024121CUP-MNDEBailleul®®2024OTC®70%2024 GMP2023GMPFDA 20244 CU-30101202472024731 2024 CATAME® 202363034.3178.3%202463095.6 202463045.2202363013.132.1 202463050.3202363021.3136.8%202363062%202453%2023123148%5 (i)(ii)(iii)202363021.544.6%202463011.9(i)(ii) 科笛集團 202363032.363.5%202463011.82023 202363058.078.3%2024630103.5 202463099.0202390.19.8%(i)(ii) 202363087.923.1%202463067.6 20236301.7182.4%20246304.8 20246302023630 20236301,454.32024 2024630200.920236301,640.31,439.4 (i)(ii)(iii) 科笛集團 (i)(ii)CU-40102CUP-MNDECUP-SFJH(CU-10201) 2024630276.020231231473.141.7% 2024630244.020231231330.226.1% 2024630519.120231231469.310.6% 20246301,210.1276.0237.8170.3 202463015 2024630 202463021.2%2023123121.0%100% 2024630 202463020.1202312313.2 2024630 202463020231231 202463020231231 科笛集團 2024630 392.7356.8 2024630 20246303602024630113.72023630134.42024630 2024630571XV(i)XV78(ii)352(iii) 2024630XVXV78352 2024630XV23336 4HongShan Capital Growth Fund V, L.P.HongShan Growth Fund V5HSG Growth V Holdco Q, LtdHSG Growth5HSG Growth V Management, L.P.HSG Management5HSG Holding Limited5SNP China Enterprises Limited55FIL Limited6Pandanus Partners L.P.6Pandanus Associates Inc.6 1. 2.AuroraCutis Limited53,642,920Aurora Cutis LimitedFutu Trustee LimitedFutu Trustee LimitedAurora CutisIIAurora Cutis LimitedIFutuTrustee LimitedAuroraCutis Limited2024630376,100I 3.6 Dimensions LP6 Dimensions Affiliates Fund, L.P.6 Dimensions Affiliates6Dimensions Capital GP, LLC6 Dimensions Capital GP, LLC6 Dimensions LP6Dimensions Affiliates 4.YF Dermatology LimitedYunfeng LPYunfeng LPYunfeng GPYunfeng GP60%40%YunfengLPYunfeng GPYF Dermatology Limited 5.HongShanGrowthHongShanGrowth Fund VHongShanGrowth Fund VHSGManagementHSGManagementHSGHolding Limited HSG Holding LimitedSNPChinaEnterprisesLimitedSNP China Enterprises LimitedHongShan Growth Fund VHSG ManagementHSG Holding Limited SNP China Enterprises LimitedHongShan Growth 6.Fidelity China Special Situations PLCFidelity Investment FundsFidelity FundsFILLimitedFIL LimitedPandanusPartners L.P.PandanusPartnersL.P.PandanusAssociates Inc.FILLimitedPandanus Partners L.P.PandanusAssociates Inc.FidelityChina Special Situations PLCFidelity FundsFidelity Investment Funds202435Fidelity Funds 2024630336 2024630 2024630585,8004.20.19223% 科笛集團 13.2013.2113.22 2024630 2024630202463020246300% 2019823 1. (a) (b) (c) 70,685,670 68,288,26022.4% (e) Aurora Cutis LimitedFutu Trustee LimitedFutuTrustee LimitedI20211025I53,642,920Aurora Cutis LimitedII2024630376,100I AuroraCutisIIIIFutuTrustee Limited2023121FutuTrustee LimitedII8,572,580IIII III 6,786,920 (f) (1)(2) (g) 1020198235 (a) (b) (i)(ii)(iii)100%(iii)10%110% 100% (c) 10(a)(b)(c) (d) (a) (b) (c) (i)(ii)(iii)(iv) 20241120236122024630 2024630 (1)20%48(2)(3)9.6 (i)(ii)(iii) 20241120236122024630 2024630 (i)35,747,115202463011.7%(ii)20,049,83520246306.6%(iii)15,697,28020246305.2% 科笛集團 (1)25%202211325%(2)(3)0.00002 2. 2023530 (a) (b) (a)(b) (c) (i)(iv)(v)10%30,402,446202411202463030,402,44630,402,4469.98% (ii)(i)1%3,040,24420241120246303,040,244 (iii)(iv)(1)(2)13.39(6)13.39(7)13.40 13.4113.4213.36(2)(a)(1)(2) (iv)10% (v)(iv) (d) 121% (e) 121012 (f) (i)(ii)(iii) (g) 10 202411202463030,402,446 (h) 1020235309 2024630 202463020247320 13.51B(1) 科笛集團 2024630 2024630 20246302023630 202361220246302410 Cutia Therapeutics 2024829 Ernst & Young27/F, One Taikoo Place97927 Tel+852 2846 9888Fax+852 2868 4432ey.com 979 King’s RoadErnst & Young27/F, One Taikoo Place979 King’s RoadQuarry Bay, Hong Kong Cutia Therapeutics 3554CutiaTherapeutics2024630343434 2410 34 2024829 2024630 20246 30 2024630 2024630 2024630 1. 1.1 CutiaTherapeutics201951520236124thFloor,Harbour Place, 103 South Church Street, P.O. Box 10240, Grand Cayman KY1-1002, CaymanIslands 1.2 2024